19th International Conference on Advanced Technologies & Treatments for Diabetes “ATTD” Mar 14, 2026 Supporting Materials COVALENT-111: 52-Week Efficacy and Safety of Icovamenib in Insulin-Deficient Type 2 Diabetes 1.4 MB
